vimarsana.com

Page 122 - அனைத்தும் நிப்பான் வானெறிக்குழுப்பெயர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Japan instructs domestic carriers to ground Boeing 777s following major incident - World News

2021-02-22 06:40:45 GMT2021-02-22 14:40:45(Beijing Time) Sina English Japan s Ministry of Land, Infrastructure, Transport and Tourism has ordered domestic carriers to halt flights of Boeing 777s after an incident involving the aircraft sparked concern, local media reported Monday. The transport ministry here was alarmed when a Boeing 777 jet engine failed shortly after the plane had taken off in the United States. The United Airlines Boeing 777-200 aircraft, on a flight from Denver, Colorado, lost large engine parts that fell onto a residential area. The plane managed to land safely, local officials and media reports said. The transport ministry s order to halt operations of Boeing 777s was given to All Nippon Airways, which has 19 Boeing 777 jets with the same type of engine among its fleet, and Japan Airlines which has 13 of the jets.

ANA, DHL pair up for delivery of Pfizer s COVID-19 vaccine to Japan

Share Pfizer, DHL Global Forwarding Japan and All Nippon Airways (ANA) have commenced distribution of COVID-19 vaccines under a joint partnership for the international transportation of vaccines between Belgium and Japan. While there are a number of key challenges involved in the transportation and distribution of vaccines and other pharmaceutical supplies, Pfizer, DHL and ANA respectively boast exceptional track record in the delivery of pharmaceutical goods, and have jointly established a reliable and efficient operation structure for the vaccine delivery from Belgium to Japan. Pfizer, over 60 years in Japan, brings therapies to people that extend and significantly improve their lives by applying science and our global resources. The vaccine, which is based on BioNTech’s proprietary mRNA technology, was developed by both BioNTech and Pfizer. Under the terms of the final agreement signed by MHLW and Pfizer Japan Inc., approximately 144 million doses of this vaccine will be supp

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.